Plug Power Stock Popped After-Hours: Key Drivers for 2026
Plug Power stock popped after-hours following a strong Q4 showing and raised 2026 guidance. This article breaks down ...
When To Rebalance Crypto Portfolio
Timing for rebalancing crypto portfolios depends on volatility, drift from targets, and your risk tolerance, with clear trigger rules.
19,022 articles
Fuel Tech (FTEK) 2025 Investment Outlook and Strategy
A practical guide to understanding Fuel Tech (FTEK) in 2025. Learn what to watch in Q4 results, identify catalysts, a...
Multistage (NCSM) 2025 Earnings: Q4 Review and Outlook
NCS Multistage's Q4 2025 earnings call offers insight into margins, backlog, and growth drivers. This guide translate...
Why Retirees Relying on ETFs Might Miss a Key Income Layer
Retirees who depend solely on dividend-focused ETFs may be trimming potential income. Experts urge adding a deliberat...
Bloom Energy Stock: Buy, Sell, or Hold? A Practical Guide
Investors are weighing bloom energy stock: buy options as the company scales its solid oxide fuel cells for AI data c...
Marvell Technology Shares Jump: Is Now the Time to Buy?
Marvell Technology has surged as AI workloads push demand for data-center hardware. This article breaks down the driv...
Biggest Risk Nvidia Stock: What Could Stop the Rally
Nvidia has dazzled investors with AI-driven growth, but a hidden threat could derail the rally. This article identifi...
Microsoft Amazon: Which Stock Is Best for AI Bets Right Now
AI is reshaping big tech, but not all bets are the same. This guide weighs Microsoft and Amazon on AI power, cash flo...
QuantumScape Stock Down 63%: Is It Time to Buy for the Long Haul?
QuantumScape faces a volatile path from lab breakthroughs to mass production. This guide breaks down what the stock d...
Prediction: Nvidia Will Soar by End of 2026 Stock Outlook
Nvidia is facing a mixed start to 2026, but the long-term case remains intact. This article explains why a 40% jump b...
Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Why Trade Desk Fell Again Today: What It Means for Investors
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status